Sobi Invites Investors to Q4 and FY 2025 Report
Sobi is set to publish its comprehensive report outlining the financial results for the fourth quarter and full year of 2025. The release is scheduled for February 5, 2026, at 08:00 CET. This report will provide crucial insights for investors interested in the company’s performance and future strategies.
Conference Call Details
On the same day as the report release, Sobi will hold a conference call at 13:00 CET, 12:00 GMT, and 07:00 EST. This event will feature an in-depth presentation of the results followed by a question and answer session. Participants are encouraged to join and engage with Sobi’s leadership team.
How to Join the Call
To participate in the call, interested parties should mark their calendar and use the dial-in numbers provided:
- Sweden: +46 8 5051 0031
- United Kingdom: +44 207 107 06 13
- United States: +1 631 570 56 13
For dial-in details specific to other countries, Sobi has made additional resources available online.
Live Presentation and Materials Accessibility
Participants can access the live presentation of the results via Sobi’s official platform. After the event, the presentation materials will be posted for those who wish to review the information at their convenience. This ensures that all interested stakeholders have the opportunity to stay informed about Sobi's updates and performance.
About Sobi
Sobi is a pioneering player in the biopharmaceutical sector, dedicated to unlocking the potential of innovative treatments for rare diseases. With a global workforce of around 1,900 employees, Sobi operates across various regions including Europe, North America, the Middle East, Asia, and Australia. In recent years, the company has demonstrated significant financial growth, with 2024 revenues reported at SEK 26 billion. Sobi’s publicly traded shares (STO: SOBI) are listed on Nasdaq Stockholm, showcasing its commitment to transparency and shareholder value.
Get in Touch with Sobi
For further details or inquiries concerning the Sobi Investor Relations Team, stakeholders are invited to explore Sobi's official channels. This is an excellent way to ensure all questions and interests can be addressed appropriately.
Frequently Asked Questions
When will Sobi's Q4 2025 report be published?
The Q4 2025 report will be published on February 5, 2026, at 08:00 CET.
How can I participate in the conference call?
You can join the conference call using the respective dial-in numbers for your region on the same day as the report release.
Where can I find the presentation slides?
The presentation slides will be available on Sobi's official website before the conference call.
What is Sobi's main area of focus?
Sobi focuses on developing innovative treatments, particularly for individuals living with rare diseases.
How many employees does Sobi have?
Sobi employs approximately 1,900 individuals worldwide, with offices in various regions including Europe and North America.